Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2013-12-06

FDA Approved: SOVALDI — Original Application (Gilead Sciences, Inc.)

View source ↗

Summary

The FDA approved Sovaldi (sofosbuvir) from Gilead as the original application, establishing it as a treatment for hepatitis C infection.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Sovaldi (Sofosbuvir)

Snippet

ORIG AP for SOVALDI (SOFOSBUVIR)